Anticancer Agents from Natural Products

Published:
Editor(s):

Purchasing Options

Hardback
Not available
in your region
ISBN 9780849318634
Cat# 1863
 

Features

  • Includes up-to-date coverage of a field that is scattered among different journals and review articles
  • Discusses current drugs in preclinical or clinical development, a source of next-generation anticancer drugs
  • Presents the latest information authored by leading scientists on each drug, including the discovery and development of Taxol®
  • Highlights antitumor properties such as selective or non-selective anti-proliferative behavior
  • Illustrates the application of modern biochemical and chemical methodologies to drug lead optimization
  • Contains a complete list of approved antitumor agents through 2002
  • Summary

    Plants, marine organisms, and microorganisms have evolved complex chemical defense and signaling systems that are designed to protect them from predators and provide other biological benefits. These organisms thus produce substances containing novel chemotypes that may have beneficial effects for humans. As collection methods improve and new screening techniques and molecular targets proliferate, natural products are once again taking a central part of modern pharmaceutical research. Anticancer Agents from Natural Products analyzes current clinically-used anticancer agents that are natural products or clearly derived from natural product leads.

    This multi-authored volume provides a historical, biochemical, and chemical rationale to the search for plant, marine, or microbial sources that may provide future templates for drug lead optimization and synthetic drug design. Grouped by source organism, each chapter includes the history of the drug and a discussion of its mechanism in action, medicinal chemistry, and biochemistry. The authors characterize each compound by its structure, genetics, molecular biology, synthesis, and possible derivatives. They also discuss \approaches to drug discovery and development, including the use of combinatorial biosynthetic techniques, testing methods, and ways to obtain economically viable amounts of the drug. The final chapter covers drug candidates that are in preclinical or clinical development and may be used in the future.

    Edited by leading scientists who have contributed enormously to natural product development and potential anticancer natural products, Anticancer Agents from Natural Products is a convenient summary of the current status of research and development of some of the most effective anticancer agents available today. It is an ideal foundation for scientists engaged in developing new and improved drugs based on natural sources.

    Table of Contents

    Introduction; G.M. Cragg, David G. I. Kingston, and D.J. Newman

    Camptothecin and its Analogs; N.J. Rahier, C.J. Thomas, and S.M. Hecht

    The Discovery and Development of the Combretastatins; K.G. Pinney, C. Jelinek, K. Edvardsen, D.J. Chaplin, and G.R. Pettit

    Homoharringtonine and Related Compounds; H. Itokawa, X. Wang, and K.-H. Lee

    Podophyllotoxins and Analogs; K.-H. Lee and Z. Xiao

    Taxol and Its Analogs; David G. I. Kingston

    The Vinca Alkaloids; F. Guéritte and J. Fahy

    The Bryostatins; D.J. Newman

    The Isolation, Characterization, and Development of a Novel Class of Potent Antimitotic Macrocyclic Depsipeptides: The Cryptophycins; R.S. Al-Awar and C. Shih

    Chemistry and Biology of the Discodermolides, Potent Mitotic Spindle Poisons; S.P. Gunasekera and A.E. Wright

    The Dolastatins: Novel Antitumor Agents from Dolabella auricularia; E. Flahive and J. Srirangam

    Ecteinascidin 743 (ET-743; Yondelis™), Aplidine, and Kahalalide F; R. Henriquez, G. Faircloth, and C. Cuevas

    Discovery of E7389, a Fully Synthetic Macrocyclic Ketone Analog of Halichondrin B; M.J. Yu, Y. Kishi, and B.A. Littlefield

    HTI-286, A Synthetic Analog of the Antimitotic Natural Product Hemiasterlin; R.J. Andersen and M. Roberge

    The Actinomycins; A.B. Mauger and H. Lackner

    Anthracyclines; F.M. Arcamone

    Ansamitocins (Maytansinoids); T.-W. Yu and H.G. Floss

    Benzoquinone Ansamycins; K.M. Snader

    Bleomycin Group of Antitumor Agents; S.M. Hecht

    Biochemical and Biological Evaluation of (+)-CC-1065 Analogs and Conjugates with Polyamides; R. Kumar and J.W. Lown

    Epothilone, a Myxobacterial Metabolite with Promising Antitumor Activity; G. Höfle and H. Reichenbach

    Enediynes; P.R. Hamann, J. Upeslacis, and D.B. Borders

    The Mitomycins; W.A. Remers

    Staurosporines and Structurally Related Indolocarbazoles as Antitumor Agents; M. Prudhomme

    Combinatorial Biosynthesis of Anticancer Natural Products; M.G. Thomas, K.A. Bixby, and B. Shen

    Developments and Future Trends in Anticancer Natural Products Drug Discovery; D.J. Newman and G.M. Cragg
    Index

    Editorial Reviews

    "The book brings home to us not only the amazing chemical complexity of the natural world but also the vast reservoir of potential new healing agents that yet remain to be tapped. This impressive work, which maintains a uniformly high standard throughout, will be of major benefit to a wide readership… .It seems likely that it will remain the definitive work in its genre for many years to come."
    -Chemistry World Vol. 3, No. 3, March 2006

    "Edited by leading scientists who have contributed enormously to natural product development and potential anticancer natural products, Anticancer Agents from Natural Products is a convenient summary of the current status of research and development of some of the most effective anticancer agents available today. It is an ideal foundation for scientist engaged in developing new and improved drugs based on natural sources."

    – In Memoriile Sectiilor Stintifice, 2006

    Related Titles